Lawyers will submit a one-page summary for each Paraquat bellwether lawsuit being prepared for early trial dates by December 16, which will be reviewed during a case management conference.
Plaintiffs who fail to pursue evidence that establishes their exposure to the toxic herbicide may have their Paraquat Parkinson’s disease lawsuits dismissed without prejudice next month.
Hearing aids may help reduce strain on the brain from hearing loss, and reduce the risk of cognitive decline or other effects of Parkinson’s.
Paraquat has already been banned in the EU, Canada, Brazil, China and dozens of other countries, the lawmakers noted.
Parkinson's disease advocacy group urges Australian citizens to sign a petition to outlaw Paraquat use in that nation.
Research indicates that individuals diagnosed with Parkinson’s disease were more likely to have suffered gastrointestinal damage from popular drugs like Nexium, Prilosec, Aleve and Motrin.
Tests on human cell lines revealed exposure to Paraquat caused build-up in proteins linked to the development of several neurodegenerative diseases.
Canadian court determined a Paraquat class action for Parkinson's disease claims will be less of a burden on the judicial system and the parties than resolving individual lawsuits.
MDL judge dismissed first group of Paraquat bellwether lawsuits in April, after excluding plaintiffs' expert witnesses from testifying at trial.
The Court determined that there were deficiencies in the experts determination that there is a causal link between Paraquat and Parkinson's disease, rendering the testimony insufficiently reliable to allow a jury to consider it at trial.
